Sophiris Bio Company Profile (NASDAQ:SPHS)

About Sophiris Bio

Sophiris Bio logoSophiris Bio, Inc., formerly Protox Therapeutics Inc., is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases. The Company has operations based in San Diego developing a treatment for benign prostatic hyperplasia (benign prostatic hyperplasia (BPH) or enlarged prostate). The Company has partnered with Kissei Pharmaceuticals for the development and commercialization of PRX302 in Japan. Sophiris Bio, Inc. is advancing a pipeline of receptor targeted fusion proteins based on three complementary technology platforms: PORxin, INxin and HUMxin. It focuses on diseases of the prostate via its PORxin platform candidate, PRX302, which has completed three clinical trials for the treatment of BPH, as well as two clinical trials for the treatment of localized recurrent prostate cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SPHS
  • CUSIP:
Key Metrics:
  • Previous Close: $3.08
  • 50 Day Moving Average: $3.544
  • 200 Day Moving Average: $2.479
  • 52-Week Range: $0.67 - $8.55
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.22
  • P/E Growth: 0.000
  • Market Cap: $70.00M
  • Outstanding Shares: 22,618,000
  • Beta: 1.78
Profitability:
  • Return on Equity: -826.95%
  • Return on Assets: -144.07%
Debt:
  • Debt-to-Equity Ratio: 3.56%
  • Current Ratio: 3.02%
  • Quick Ratio: 3.02%
Additional Links:
Companies Related to Sophiris Bio:

Analyst Ratings

Consensus Ratings for Sophiris Bio (NASDAQ:SPHS) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (109.00% upside)

Analysts' Ratings History for Sophiris Bio (NASDAQ:SPHS)
Show:
DateFirmActionRatingPrice TargetDetails
9/15/2016Roth CapitalInitiated CoverageBuy$8.00View Rating Details
8/30/2016Piper Jaffray Cos.Initiated CoverageOverweight -> Overweight$7.00View Rating Details
8/10/2016Maxim GroupBoost Price TargetBuy$4.00 -> $6.00View Rating Details
6/10/2016Echelon Wealth PartnersReiterated RatingBuy$5.00View Rating Details
12/18/2014Stifel NicolausDowngradeBuy -> Hold$7.00View Rating Details
10/16/2014Leerink SwannInitiated CoverageOutperform$5.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Sophiris Bio (NASDAQ:SPHS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016        
5/16/2016Q1($0.19)($0.13)ViewN/AView Earnings Details
3/23/2016Q4($0.15)ViewN/AView Earnings Details
11/16/2015Q3($0.22)ViewN/AView Earnings Details
5/13/2015($0.30)($0.26)ViewN/AView Earnings Details
3/10/2015($0.47)($0.31)ViewN/AView Earnings Details
11/13/2014($0.54)($0.49)ViewN/AView Earnings Details
5/13/2014Q114($0.50)($0.52)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sophiris Bio (NASDAQ:SPHS)
Current Year EPS Consensus Estimate: $-0.51 EPS
Next Year EPS Consensus Estimate: $-0.50 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20162($0.09)($0.07)($0.08)
Q4 20162($0.08)($0.06)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Sophiris Bio (NASDAQ:SPHS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sophiris Bio (NASDAQ:SPHS)
Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 5.29%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2014Boxer Capital, LlcMajor ShareholderSell881,479$0.61$537,702.19View SEC Filing  
11/14/2014Randall E WoodsInsiderBuy3,000$2.43$7,290.00View SEC Filing  
9/19/2014Gerald T ProehlDirectorBuy10,000$3.16$31,600.00View SEC Filing  
7/10/2014Randall E WoodsInsiderBuy1,000$2.65$2,650.00View SEC Filing  
7/9/2014Randall E WoodsInsiderBuy1,000$2.66$2,660.00View SEC Filing  
6/6/2014James L HeppellDirectorSell19,231$2.59$49,808.29View SEC Filing  
8/22/2013Randall E WoodsCEOBuy2,500$4.50$11,250.00View SEC Filing  
8/20/2013Peter T SloverCFOBuy4,680$4.25$19,890.00View SEC Filing  
8/19/2013Randall E WoodsCEOBuy10,000$4.29$42,900.00View SEC Filing  
8/16/2013Boxer Capital, LlcMajor ShareholderBuy1,600,000$5.00$8,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sophiris Bio (NASDAQ:SPHS)
DateHeadline
News IconVolatile Stocks Under Street Updates- Abbott Laboratories (NYSE:ABT), Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Wise Report (press release) (blog) (NASDAQ:SPHS)
streetwisereport.com - September 27 at 7:21 PM
News IconUnder the Microscope: Zeroing in on Shares of Sophiris Bio, Inc ... - Duncan Research (NASDAQ:SPHS)
www.duncanindependent.com - September 26 at 7:26 PM
News IconSell-Side Predicting Sophiris Bio, Inc. (NASDAQ:SPHS) Stock Will Touch Between $6-8 - Frisco Fastball (NASDAQ:SPHS)
friscofastball.com - September 26 at 10:47 AM
News IconKeen Investors Find News on Sophiris Bio, Inc. (NASDAQ:SPHS) - Duncan Research (NASDAQ:SPHS)
www.duncanindependent.com - September 24 at 11:46 AM
News IconNoticeable Stock: Sophiris Bio, Inc. (SPHS), Cameco Corporation (CCJ) - Newburgh Press (NASDAQ:SPHS)
newburghpress.com - September 22 at 11:58 AM
capitalcube.com logoSophiris Bio, Inc. :SPHS-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016 (NASDAQ:SPHS)
www.capitalcube.com - September 21 at 11:31 AM
4-traders.com logoNeurocrine Biosciences : Generic Drugs Stocks on Investors' Radar -- Zoetis, Sophiris Bio, Rigel Pharma, and Neurocrine Biosciences (NASDAQ:SPHS)
www.4-traders.com - September 20 at 11:34 AM
streetinsider.com logoPre-Open Stock Movers 09/15: (AERI) (ACRX) (NTWK) Higher; (SQNS) (PAH) (SRPT) Lower (more...) (NASDAQ:SPHS)
www.streetinsider.com - September 15 at 11:03 AM
thestreet.com logoSophiris Bio (SPHS) Stock Coverage Initiated at Roth Capital (NASDAQ:SPHS)
www.thestreet.com - September 15 at 11:03 AM
News IconKeen Investors Narrowing Their Focus on Sophiris Bio, Inc. (NASDAQ:SPHS) - Duncan Research (NASDAQ:SPHS)
www.duncanindependent.com - September 14 at 7:33 PM
News IconSophiris Bio Inc (NASDAQ:SPHS): Bias Vinidcated, Reinforced and Restated - Street Register (NASDAQ:SPHS)
streetregister.com - September 14 at 7:33 PM
News IconHC Stocks News Ring= Sophiris Bio Inc (SPHS), Idera ... - share market updates (press release) (NASDAQ:SPHS)
sharemarketupdates.com - September 14 at 7:33 PM
News IconSophiris Bio Inc (NASDAQ:SPHS): Bias Vinidcated, Reinforced and Restated (NASDAQ:SPHS)
streetregister.com - September 13 at 12:17 PM
News IconSophiris Bio, Inc. (NASDAQ:SPHS) are Projected to Reach 6.5, According to Analysts - Frisco Fastball (NASDAQ:SPHS)
friscofastball.com - September 12 at 6:58 PM
News IconSophiris Bio, Inc. (NASDAQ:SPHS) Shares in Focus As Analysts Agree on a Consensus Target - Frisco Fastball (NASDAQ:SPHS)
friscofastball.com - September 12 at 6:58 PM
finance.yahoo.com logoSPHS: Initiating on Sophiris Bio, Inc.; Developing Novel Treatments for Urologic Conditions (NASDAQ:SPHS)
finance.yahoo.com - September 12 at 6:58 PM
istreetwire.com logo3 Notable Runners: Thomson Reuters Corporation (TRI), Sophiris Bio, Inc. (SPHS), Brookdale Senior Living Inc. (BKD) - iStreetWire (NASDAQ:SPHS)
istreetwire.com - September 8 at 11:15 AM
News IconNotable Stock's Buzzers: KKR & Co. L.P.(NYSE:KKR), Sophiris Bio Inc (NASDAQ:SPHS), Michaels Companies Inc ... - NYSE Journal (press release) (NASDAQ:SPHS)
stockznews.com - September 7 at 11:08 AM
News IconIs the Price Target of 6.5 To Far Fetched for Sophiris Bio, Inc. (NASDAQ:SPHS)? - Frisco Fastball (NASDAQ:SPHS)
friscofastball.com - September 3 at 11:26 AM
News IconHC Stock News: Sophiris Bio Inc (NASDAQ:SPHS) - share market updates (press release) (NASDAQ:SPHS)
sharemarketupdates.com - September 2 at 12:18 PM
schaeffersresearch.com logoAnalyst Upgrades: United Continental Holdings Inc, Sophiris Bio Inc, and VMware, Inc. - Schaeffers Research (blog) (NASDAQ:SPHS)
www.schaeffersresearch.com - August 30 at 10:46 AM
publicnow.com logoSophiris Bio Closes Underwritten Public Offering (NASDAQ:SPHS)
www.publicnow.com - August 26 at 7:09 PM
News IconSophiris Bio Inc. (NASDAQ:SPHS): Sabby Capital Reports Large New Stake (NASDAQ:SPHS)
feedproxy.google.com - August 25 at 10:13 PM
News IconIs Sophiris Bio Inc (NASDAQ:SPHS) About To Announce A Big Pharma Partnership? (NASDAQ:SPHS)
streetregister.com - August 25 at 7:45 PM
News IconIs Sophiris Bio Inc (NASDAQ:SPHS) About To Announce A Big Pharma Partnership? - Street Register (NASDAQ:SPHS)
streetregister.com - August 25 at 12:25 PM
News IconSophiris Bio Inc. Shares Slide After Stock Offering (NASDAQ:SPHS)
sdbj.com - August 24 at 7:15 PM
rttnews.com logoSPHS Prices Offering At $4.00/share And Related Warrant (NASDAQ:SPHS)
www.rttnews.com - August 24 at 7:15 PM
streetinsider.com logoSophiris Bio (SPHS) Prices Common Stock, Warrants Offering for Proceeds of $26M (NASDAQ:SPHS)
www.streetinsider.com - August 24 at 7:15 PM
News IconActive Stock's Momentum: Sophiris Bio Inc (NASDAQ:SPHS), Rite Aid Corporation (NYSE:RAD) - NYSE Journal (press release) (NASDAQ:SPHS)
stockznews.com - August 24 at 10:38 AM
News IconMovers to Watch - Petroleo Brasileiro SA Petrobras (NYSE:PBR), Sophiris Bio Inc (NASDAQ:SPHS) - Money News (press release) (NASDAQ:SPHS)
www.newsismoney.com - August 23 at 7:39 PM
nasdaq.com logoSophiris Bio Prices Public Offering of Shares and Warrants; Shares Tumble Pre-Market (NASDAQ:SPHS)
www.nasdaq.com - August 23 at 12:02 PM
publicnow.com logoSophiris Bio Prices Public Offering of Common Shares and Warrants (NASDAQ:SPHS)
www.publicnow.com - August 23 at 12:02 PM
thestreet.com logoSophiris Bio (SPHS) Stock Tumbles on Public Offering (NASDAQ:SPHS)
www.thestreet.com - August 23 at 12:02 PM
marketwatch.com logoSophiris Bio's stock plunges to pace Nasdaq losers after discounted share offering (NASDAQ:SPHS)
www.marketwatch.com - August 23 at 12:02 PM
publicnow.com logoSophiris Bio Announces Proposed Public Offering of Common Shares and Warrants (NASDAQ:SPHS)
www.publicnow.com - August 22 at 7:25 PM
marketwatch.com logoSophiris Bio shares tank on secondary stock offering (NASDAQ:SPHS)
www.marketwatch.com - August 22 at 7:25 PM
News IconVolatile Session Ends on Positive Note (NASDAQ:SPHS)
www.fxstreet.com - August 19 at 10:29 AM
News IconNASDAQ Index Relatively Benign Today on Low Volatility (NASDAQ:SPHS)
www.economiccalendar.com - August 18 at 7:48 PM
smarteranalyst.com logoMaxim Raises Price Target For Sophiris Bio Inc (SPHS) Following ... - Smarter Analyst (NASDAQ:SPHS)
www.smarteranalyst.com - August 12 at 7:40 PM
smarteranalyst.com logoCompany Update (NASDAQ:SPHS): Sophiris Bio Inc Reports ... - Smarter Analyst (NASDAQ:SPHS)
www.smarteranalyst.com - August 11 at 8:05 PM
smarteranalyst.com logoMaxim Raises Price Target For Sophiris Bio Inc (SPHS) Following 2Q Update - Smarter Analyst (NASDAQ:SPHS)
www.smarteranalyst.com - August 11 at 8:05 PM
smarteranalyst.com logoCompany Update (NASDAQ:SPHS): Sophiris Bio Inc Reports Second Quarter 2016 Financial Results and Key ... - Smarter Analyst (NASDAQ:SPHS)
www.smarteranalyst.com - August 9 at 7:50 PM
finance.yahoo.com logo4:33 pm Sophiris Bioc reports Q2 results, update (NASDAQ:SPHS)
finance.yahoo.com - August 9 at 7:50 PM
publicnow.com logoSophiris Bio Reports Second Quarter 2016 Financial Results and Key Business Highlights (NASDAQ:SPHS)
www.publicnow.com - August 9 at 7:50 PM
streetupdates.com logoStocks Movements to Focus: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Updates (NASDAQ:SPHS)
www.streetupdates.com - August 4 at 10:43 AM
fortune.com logoNotable Analyst Views: Sophiris Bio Inc (NASDAQ:SPHS), American Axle & Manufact. Holdings, Inc. (NYSE:AXL) - Review Fortune (NASDAQ:SPHS)
reviewfortune.com - August 3 at 7:54 PM
fortune.com logoSophiris Bio, Inc. (NASDAQ:SPHS) Insider Activities Are in the Air - Review Fortune (NASDAQ:SPHS)
reviewfortune.com - August 3 at 7:54 PM
News IconStock to keep an eye on: Sophiris Bio, Inc. (NASDAQ:SPHS) - News Oracle (NASDAQ:SPHS)
www.newsoracle.com - August 3 at 7:54 PM
streetupdates.com logoInvestors Spotlight: Alere Inc. (NYSE:ALR) , Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Updates (NASDAQ:SPHS)
www.streetupdates.com - July 29 at 7:42 PM
fortune.com logoSophiris Bio, Inc. (NASDAQ:SPHS): Updated Analyst Ratings - Review Fortune (NASDAQ:SPHS)
reviewfortune.com - July 29 at 7:42 PM

Social

Sophiris Bio (NASDAQ:SPHS) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff